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Epidermoid carcinomas represent from 90% to 95% of 
oral cavity malignant neoplasias, making up 13,470 cases/
year. Aims: To correlate p53 and Ki-67 expressions in mouth 
and tongue carcinomas with lymph node status, gender, 
histological grade, tumor volume and pathological stage. 
Materials and Methods: We carried out a retrospective study 
of 28 cases of mouth and tongue epidermoid carcinomas. 
They were submitted to immunohistochemical study in order 
to check the expression of p53 and Ki-67 antibodies and 
statistically compare them in terms of lymph node status, 
gender, histological grade, tumor volume and pathological 
staging. Results: The individually analyzed p53 proved to 
have statistical significance (p<0.05) when compared to 
tumor volume (p=0.029). Despite a strong tendency, the 
p53/tumor volume relation was not significant. When p53 + 
Ki67 were analyzed, tumor volume had p < 0.05 (p = 0.029). 
Discussion: Literature shows that the expression of p53 
and Ki-67 is related to the presence of metastasis to lymph 
nodes and a worse prognosis. Conclusion: In oral cavity and 
tongue epidermoid carcinomas, p53 and Ki-67 are related to 
larger tumors, metastasis to lymph nodes and very likely to 
a worse prognosis.
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INTRODUCTION
Epidermoid carcinomas represent 90% to 95% 
of the oral cavity malignant neoplasias, especially in-
volving the posterior lateral border of the tongue. It 
usually affects men above 50 years of age, most with a 
past of high consumption of tobacco, alcohol, excessive 
exposure to sun light, bad mouth hygiene, diets poor in 
fruits and vegetables, secondary infection by the human 
papillomavirus (HPV) and Herpes Simplex Virus (HSV-1), 
and these factors are considered of high risk for cancer 
development1-3.
The tongue and oral cavity epidermoid carcinoma 
is responsible for approximately 30,990 new cases of 
cancer in the USA per year - according to 2006 estimates, 
of which 7,430 deaths are expected. It is responsible for 
1.3% of all cancer-related deaths. In Brazil we estimate 
an incidence of around 13,470 new cases, 10,060 in men 
and 3,410 in women. Epidermoid carcinoma is the most 
common malignant neoplasia in the oral cavity, being 
responsible for 2.1% of all the malignant neoplasias in 
men and 0.7% in women. The age of highest incidence 
is the seventh decade of life, frequently associated to 
leaves of absence from work. The prognostic evaluation 
of this neoplasia is given by histological and immuno-
histochemical findings, including staging, histological 
grade, tumor size, lymph node involvement, immuno-
histochemical expression of p53 and Ki-67. The staging 
of this neoplasia is done according to the TNM system 
of the International Union Against Cancer (UICC), with 
assessment of tumor size and lymph node involvement. 
Epidermoid carcinomas can be differentiated or keratini-
zed (histological grade I), or moderately or little differen-
tiated (histological grades II and III). Invasive neoplasias 
which measure from 0 to 2.0cm are classified as T1 and 
the ones measuring 2.0 to 4.0 are T2 and the ones larger 
than 4cm are T3. When adjacent tissue is invaded, they 
are graded as stage T4, regardless of size. Even small 
lesions can be classified as T4, which are associated with 
a worse prognosis.
With the technological progress in image diagnostic 
methods (CT scan and MRI), the medical knowledge also 
broadens. Medical literature has had a growing number of 
papers trying to assess tumor volume as an independent 
prognostic factor in carcinomas that affect the tongue, na-
sopharynx and lungs. Some studies are able to prove this 
theory; however the literature is still very controversial.
Lymph node involvement is still considered one 
of the major prognostic markers of these neoplasias. Ac-
cording to the TNM system, the involvement of a single 
ipsilateral lymph node of up to 3cm in its largest axis is 
classified as N1. N2 corresponds to the cases with single 
metastasis in ipsilateral lymph node measuring between 
3 and 6cm or multiple uni or bilateral lymph nodes smal-
ler than 6cm. In N3 we find the cases with metastasis to 
lymph nodes larger than 6cm in diameter. 
Immunohistochemical tests have been used in the 
assessment of other prognostic factors associated with 
oral cavity and tongue carcinomas, p53 and Ki-67 are 
among them. The relationship between p53 expression 
or that of Ki-67 cell proliferation marker with mouth 
epidermoid carcinoma has been broadly studied in cur-
rent times. This may be due to the social impact caused 
by this neoplasia. Cancer suppressor genes or those 
that regulate apoptosis represent an important variable 
in the equation of neoplasias, among them p53 stands 
out4-6. Results from a large number of studies have shown 
that p53 expression has a major prognostic meaning in 
different types of cancer. P53 is a proto-oncogene and 
has its role involved in controlling the cell death cycle, 
consequently in genomic stabilization. Mutated genes 
become oncogenes and lose their property of removing 
an altered cell from the cell cycle, repair it and take it 
back to the cycle or lead it to programmed cell death, 
thus causing carcinogenesis. P53 protein expression can 
be easily detected in approximately 50-60% of the cases 
of oral cavity or tongue carcinoma, which may correspond 
to an increase in protein expression or even a mutation7-9.
Today, uncontrolled cell proliferation is considered 
one of the most important biological mechanisms asso-
ciated with oncogenesis10. Results from a large number 
of studies show that the proliferation activity has a major 
prognostic meaning in a variety of tumors. Cell prolife-
ration markers have been classified in three categories: 
[1] growth fraction markers; [2] markers of specific cell 
cycle phases; and [3] cell cycle time markers. Growth 
fraction that is the ratio of cells growing within the cycle 
can be easily identified by Ki-67 or MIB-1 antibodies, 
identifying antigen expression on phases G1, S, G2 and 
M of the cell cycle11,12.
OBJETIVES
The goal of the present study was to check the 
correlation of p53 and Ki-67 immunohistochemical ex-
pression in oral cavity and tongue epidermoid carcinomas 
with lymph node stage (pN), as well as to observe marker 
expression and correlate tumor volume, patient gender, 
degree of histological differentiation and pathological 
staging (pT).
MATERIALS AND METHODS
We carried out a cross-sectional study with twenty-
eight cases of oral cavity and tongue epidermoid carcino-
mas, with positive regional lymph nodes for metastasis, 
operated upon and diagnosed between November of 
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1999 and April of 2006, corresponding to a period of 
78 months. We reviewed all the tongue and oral cavity 
tumors found in the corresponding period of time, and 
we took off the current study all the neoplasias which 
were not epidermoid carcinomas. As inclusion criteria we 
used the existence of a sample (block) for each case, a 
proper block conservation status and proper histological 
grading used when the diagnosis was standardized by 
the WHO. Thus, 28 oral cavity or tongue epidermoid 
carcinomas with neck lymph node resection were selec-
ted. As to lymph node involvement we used as criteria 
the presence of metastasis seen under light microscopy, 
the cases were broken down into two groups: (1) cases 
with negative metastatic lymph nodes and (2) cases with 
positive metastatic lymph nodes. As to the histological 
grade of the neoplasia, the cases were broken down 
into two groups: (1) low grade (including grade I / well 
differentiated) and (2) high grade (including grades II 
and III / moderately and with little differentiation). As 
to pathological staging (pT) of the neoplasias, the cases 
were broken down into two groups: (1) lesions with local 
involvement (including pT1, pT2, pT3) and (2) lesions 
involving neighboring structures (pT4). As far as tumor 
volume is concerned, the neoplasias were broken down 
into two groups: group (1) in which the neoplasias had 
a volume equal to or lower than 8cm3 and group (2) in 
which the neoplasias had a volume greater than 8cm3. 
Tumor volume calculation is done by the multiplication 
of the three values found during the macroscopic exam 
of the specimen, longitudinal axis x width x depth.
Sample collection was authorized by the guardians, 
and the research project was approved by the Ethics in 
Research Committee under protocol # CEP-2006-246H, 
within the standards which regulate research with human 
beings, according to resolution # 196/96 of the National 
Health Council - Department of Health - Brazil.
Immunohistochemistry
The cases were submitted to an immunohistoche-
mistry technique to check the expression of antibodies 
p53 and Ki67. For the immunohistochemical technique we 
used sections of tissues previously fixed in 10% formalin, 
included in paraffin blocks. From each sample we obtai-
ned histological cross-sections of 3 micrometers of width, 
which were placed on silanized slides. For the test itself, 
each slide was sent for deparaffinization with xylol and 
cross-section hydration with ethanol. Antigenic recovery 
was carried out in two microwave ovens, with a 10mM/
pH 6.0 nitric oxide solution in two 9-minute cycles each, 
at a power of 750W. The endogenous peroxidase block 
was carried out with 3% hydrogen peroxide (10 volume). 
The primary antibody was diluted in a 1% albumin solu-
tion in PBS, incubated in a moist chamber at 37˚C, and 
then the material was placed under a 4˚C refrigeration 
for 18 hours. Biotinilated antibody used a moist chamber 
at 37˚C, for 30 minutes, just like the incubation with the 
streptavidin-biotin-peroxidase (StreptABC) complex. The 
chromogenic substrate used corresponded to a 60 mg% 
diaminobenzidine in PBS, as for dye we used Harrys 
hematoxylin. The antibodies used were the p53 protein, 
DO-7 clone, monoclone (DAKO Corporation) and the 
Ki-67 antigen, MIB-1 clone, monoclonal (DAKO Corpo-
ration). The immunohistochemical expression of each 
antibody for each case was estimated by the percentage 
of cells expressing a specific color regarding the antibody 
used, and the following quantification scale was used, 
according to the Department of Pathology’s Standards, 
since there is no consensus in the literature about the 
criteria for positivity:
Negative expression: 0 to 09% of the neoplastic 
cells having antibody expression.
Positive expression: 10 to 100% of the neoplastic 
cells having antibody expression. (Figure 1)
Figure 1. Immunohistochemistry-p53 - Cells dyed in brown show a 
positive reaction.
Statistics
The statistical analysis was carried out using the 
SPSS version 12.0 software starting from the chi-squared 
test to compare categorical variables. Through the sta-
tistical analysis we assessed the combined relation be-
tween Ki-67 and p53 tumoral expression with the other 
variables studied (lymph node status, gender, histological 
grade and pathological staging of the tumors [pT]). The 
values were considered statistically significant when the 
p value was lower than 0.05 or when necessary we used 
the Fisher’s exact test, considered valid when f is lower 
than 0.05.
547
Brazilian Journal of otorhinolaryngology 75 (4) July/august 2009
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
RESULTS
The study included 28 patients with histological 
diagnosis of epidermoid carcinoma of the tongue and 
oral cavity submitted to surgery with neck lymph node 
resection.
As far as gender is concerned, 24 patients were 
males and 4 were females, which corresponded to 85.7% 
and 14.3% respectively. As to tumor differentiation, 2 
were classified as being of low grade and 26 as high 
grade, corresponding to 7.15% and 92.85%. As to tumor 
staging, 10 patients had tumors which did not invade 
adjacent structures (pT1, 2, 3) and 18 had tumors inva-
ding adjacent structures (pT4), corresponding to 35.7% 
and 64.3% respectively. Lymph node status was defined 
as positive in 14 cases and negative for metastasis in 14 
cases. As to the relationship to the expression of P53 and 
Ki67 immunohistochemical markers, p53 was expressed 
in 50% of the cases and Ki-67 expression happened in 
92.85% of the cases and the simultaneous expression of 
both happened in 50% of the cases. In terms of tumor 
volume, 25% of the tumors were smaller or equal to 8cm3 
(7 cases) and 75% of the tumors were larger than 8cm3, 
corresponding to 21 cases. (table 1)
p53+Ki-67 markers was also positive in 50% of the total 
number of cases, but only in 28.6% (4 cases) of the ca-
ses with lymph node metastasis had p value of 0.023 for 
this relationship, however the Fisher’s exact was higher 
than 0.05 (f = 0.056). Comparing the Ki-67 antigen with 
lymph node status was also not significant, p = 0.075, 
although the marker’s immunohistochemical expression 
was positive in 92.85% (26/28 cases) from the total of 
cases, although it was present in 85.7% of those with 
lymph node metastasis.
The p53 marker’s immunohistochemical expression 
was positive in 54.2% of male patients (13/24 cases) and 
25% of the patients were females (1/4 cases); notwi-
thstanding, this relationship (p53 versus gender) was 
statistically significant (p = 0.28), and when we studied 
the relationship of p53 immuno-positivity versus pT and 
histological grade, it did not yield statistical meaning in 
any of the cases, p = 0.114 and p = 0.075, respectively.
The Ki-67 marker was positive in 92.85% of the 
tumors (26/28 cases), in male patients this immuno-
positivity happened in 95.83% (23/24 cases) and in 75% 
(3/4 cases) of female patients, however this relation was 
not statistically significant (p = 0.134). As to tumoral sta-
ging, the cell proliferation marker was positive in 100% 
(10/10 cases) of the cases in which the neoplasia did 
not invade adjacent structures, that is, pT1, pT2 and pT3 
and it was positive in 88.9% (16/18 cases) of the cases in 
which the neoplasia invaded adjacent structures (pT4); 
however this ratio Ki-67 versus pT, was not statistically 
significant, p = 0.523.
The cell proliferation marker, which was positive 
in 92.85% of all the cases was positive in 100% of the 
cases classified as being of low grade (2/2 cases) and in 
92.3% of the cases classified as being of high grade (24/26 
cases), and when compared to the degree of histological 
differentiation, it did not show any significance, p = 0.578. 
The simultaneous expression of both markers p53 + ki-67 
also did not show statistical significance when correlated 
with gender, pT and histological grade, p = 0.280, p = 
0.114 and p = 0.075.
Tumor volume was greater than 8cm3 in 75% (21/28 
cases) of the cases. When tumor volume was compared 
to lymph node metastasis, tumor volume was greater 
than 8cm3 in 92.85% (13/14 cases) of the cases, this re-
lationship proved significant, p = 0.029. The p53 marker 
expressed immuno-positivity in 57.1% (12/21 cases) of 
tumors larger than 8cm3 and in only 42.9% (3/7 cases) of 
those smaller than 8cm3, the volume versus p53 relation 
proved to be statistically significant, p = 0.029. Thus, the 
p53+Ki-67 combined expression when related to tumors 
larger than 8cm3 proved to be valid, p = 0.029. However, 
the other variables in the study such as gender, degree 
Table 1. Statistical correlation of the variables studied with p53, ki-67 
and p53 + Ki-67 markers
Variables studied p53 Ki-67 p53&Ki-67
Gender
p = 0,280 p = 0,134 p = 0,280
f = 0,595 f = 0,269 f = 0,595
pT
p = 0,114 p = 0,166 p = 0,114
f = 0,236 f = 0,523 f = 0,236
pN
p = 0,023 p = 0,075 p = 0,023
f = 0,056 f = 0,481 f = 0,056
Tumor volume
p = 0,029 p = 0,269 p = 0,029
f = 0,076 f = 1,000 f = 0,076
Histological grade
p = 0,075 p = 0,578 p = 0,075
f = 0,481 f = 0,231 f = 0,481
Values < 5 in two Chi2 squares can not be used, even if p ≤ 0.05. In 
such a case one must consider the Fisher’s exact; f ≤ 0.05
As far as lymph node status is concerned, the p53 
marker immunohistochemical expression was positive 
in 50% (14/28 cases) of the cases. Of this total, 71.4% 
(10 cases) did not have metastasis for lymph nodes and 
only 28.6% (4 cases) had metastasis. When we compa-
red the p53 immuno-positivity with lymph node status 
(p = 0.023); however, the Fisher’s exact was higher than 
0.05 (f = 0.056), thus rending the relation statistically 
meaningless. The positive expression combined with the 
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of histological differentiation and tumor staging (pT) did 
not show statistical significance, p = 0.70, p = 0.75 and 
p = 0.69.
DISCUSSION
Oral cavity and tongue carcinomas are broadly 
studied and discussed in the world medical literature. 
Recent studies have clearly shown the importance of 
immunohistochemistry in the evaluation of predictive 
values and prognosis of oral cavity and tongue epider-
moid carcinomas.
This study aims at assessing the p53 and Ki-67 
immunohistochemical markers and to correlate the ex-
pression of these markers with prognostic factors, already 
known and accepted in the medical literature and others 
not so much, such as tumor volume. 
The immunohistochemical expression of p53 ha-
ppened in 50% of the cases we studied, as it happened in 
the study carried out by Nakanishi et al.11 and Forastiere et 
al.9. The statistical analysis of the p53 immuno-positivity 
correlation showed a strong trend when associated with 
the presence of metastasis to the regional lymph nodes; 
however, without statistical significance, although p = 
0.023; in these cases it was necessary to use the Fisher’s 
exact, f = 0.056. Some authors were able to prove the 
statistical significance of this relation, overexpression of 
p53 and metastasis for lymph nodes in oral cavity carci-
nomas and also in neoplasias of other primary sites, such 
as the esophagus and the brain, for instance13. Authors 
such as Oliveira et al.14,15 showed in their studies that p53 
presence is correlated to a larger number of metastasis to 
lymph nodes and, consequently, with a worse prognosis. 
According to Carlos de Vicente et al.16, the p53 immu-
noexpression had a worse prognosis in patients without 
metastasis to neck lymph nodes were strongly related. 
When p53 correlations were analyzed with other factors 
considered, such as gender (p = 0.28) and histological 
differentiation (p = 0.075) there was no statistical signifi-
cance; however Kurokawa H et al.17 concluded that p53 
overexpression on the borders of the tumor is associated 
with its histological grade (p < 0.05).
The Ki-67 cell proliferation marker was positive 
in 92.85% of the cases studied. The statistical analysis 
attempted to correlate the Ki-67 immunohistochemical 
expression with other prognostic factors related to oral 
cavity epidermoid carcinomas, however none of the 
relations established proved valid, and many papers 
have shown the importance of analyzing the rate of cell 
proliferation as a truly important prognostic factor in 
head and neck carcinomas. In our studies, we noticed a 
strong trend towards Ki-67 positive immunoexpression 
in tumors with neck metastasis - p = 0.075. According to 
Myong et al.18, the Ki-67 immunohistochemical expression 
proved to be significantly higher in patients with neck 
lymph node metastasis, thus representing an indepen-
dent prognostic factor in the survival of patients with 
oral cavity epidermoid carcinomas; pathological staging 
(pTNM) was the most important prognostic variable and 
Ki-67 expression has a significant effect on the cumulative 
survival rate of these patients. Crossovers and statistical 
analyses with other factors investigated, such as gender (p 
= 0.134), pT (p = 0.166) were not statistically significant; 
however, Ki-67 overexpression on tumor borders, accor-
ding to Kurokawa et al.17 is associated to its histological 
grade (p < 0.05).
The simultaneous immunoexpression of both 
markers, p53 and Ki-67 happened in 50% of the cases 
studied and the statistical analysis showed us that the 
co-expression of p53 and Ki-67 markers with metastasis 
to neck lymph nodes showed a strong trend in being 
valid, p = 0.023, however, in this case it was necessary 
to use Fisher’s exact, f = 0.056, thus showing that the 
relationship is not statistically significant. The literature 
shows that the co-expression of p53 and Ki-67 takes part 
in the carcinogenesis of oral cavity epidermoid carcino-
mas, thus causing cell proliferation19. Some authors, such 
as Lavertu P et al.20, safely state that the co-expression of 
p53 and Ki-67 markers is associated with a lower time 
of survival free from disease, including lower time to 
neoplasia recurrence and/or an appearance of a second 
early primary site, thus reducing the general survival rate. 
It is also worth stressing that the negative combination 
of these two markers (p53 - / Ki-67) is associated to 
a lower recurrence incidence (p = 0.02), lower loco-
regional recurrence rate (p = 0.01) and lower incidence 
of a second primary tumor (p = 0.04), as well as longer 
disease-free survival (p = 0.02). Statistical analysis did not 
prove to be significant when the marker’s co-expression 
was compared to gender and histological differentiation: 
p = 0.280 and p = 0.075, respectively.
Tumor volume calculation happened from the fact 
that the neoplasia is a solid and tridimensional mass, and 
not only a linear structure, thus a pT1 tumor (a tumor with 
2.0cm or less in its largest dimension) may have a total 
volume of 8cm3 (2.0cm X 2.0cm X 2.0cm) and a pT3 tumor 
(a tumor with more than 4.0cm in its largest dimension) 
may have a volume of 4.1cm3 ( 4.1cm X 1.0cm X 1.0cm ), 
in this case, the so-called pT1 tumor would be larger than 
the so-called pT3. It is possible to consider that, with the 
technological progress of image tests, measuring tumor 
size will become indispensable and routine to assess the 
development process and the prognosis of neoplasias 
and also that tumor volume calculation may change the 
staging process of some neoplasias or even create a new 
methodology to stage tumors, a new TNM. The threshold 
volumetric volume here established was of 8cm3, because 
the medical literature still does not have any protocol to 
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be followed. In the present study, 25% of the tumors had 
volume ≤8.0cm3 and 75% had volume >8.0cm3.
The statistical analysis, when carried out, compared 
tumor volume (> or < than 8.0cm3) with the variables in 
our study, which showed statistical significance when 
tumor volume was compared to lymph node involvement 
(pN+) (p = 0.029), tumor volume and p53 (p = 0.029) and 
tumor volume and p53+Ki-67 (p = 0.029). Some authors, 
such as Chew MH et al.21 concluded that tumor volume 
measure allows for a better and more accurate assessment 
of tumor status and will very likely become a prognostic 
indicator of a future staging model. Some papers related to 
neoplasias in sites other than the oral cavity mention the 
importance of the volumetric measure. Chua et al.22 say 
that tumor volume measuring represents a local control 
independent prognostic factor which seems to be better 
than the “t” staging of Ho’s classification in nasopharyn-
geal carcinomas. Following the same line of research, 
Lee et al.23 proved that there is a significant difference 
in the survival of patients with the larger tumors (p = 
0.044), despite the stage (p = 0.25) and/or initial pT (p = 
0.30). However, authors such as Chua et al.24 were una-
ble to statistically prove the relationship between tumor 
volume in nasopharyngeal carcinomas when compared 
to the presence of metastasis to regional lymph nodes 
and recurrence; nonetheless, it was seen that the 5 year 
surviving rate was substantially lower in those individuals 
in whom the tumor measured more than 15cm3.
In the present investigation, tumor volume measure 
did not show any statistically valid relationship when 
compared to other factors studied, gender, pT, Ki-67 and 
degree of histological differentiation.
CONCLUSION
Results from our study showed that oral cavity 
and tongue carcinomas tend to have an overexpression 
of p53 and Ki-67 in those cases with metastasis to neck 
lymph nodes. As far as tumor volume is concerned, tu-
mors larger than 8.0cm3 presented a higher incidence of 
metastasis to lymph nodes, greater p53 expression and 
co-expression of p53 and Ki-67 markers, suggesting that 
these patients have a worse prognosis.
The correlation of p53, Ki-67 and tumor volume 
with the other variables studied did not show statistical 
significance (p > 0.05).
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